ArticleBlood2022

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.

Victor Manuel Orellana-Noia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.